Your browser doesn't support javascript.
loading
Prednisone reduction for metastatic castration-resistant prostate cancer with recurrent pulmonary tuberculosis: Case report.
Zhu, Xiaojuan; Shi, Zhenguo; Gao, Shegan; Wang, Xiaohong; Wang, Pei; Kang, Chongzhao; Zhao, Fangzong; Hou, Peng.
Affiliation
  • Zhu X; Department of Radiation Oncology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.
Medicine (Baltimore) ; 100(15): e25584, 2021 Apr 16.
Article in En | MEDLINE | ID: mdl-33847689
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Pulmonary / Prednisone / Prostatic Neoplasms, Castration-Resistant / Glucocorticoids / Mycobacterium Type of study: Guideline Limits: Aged / Humans / Male Language: En Journal: Medicine (Baltimore) Year: 2021 Document type: Article Affiliation country: China Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Pulmonary / Prednisone / Prostatic Neoplasms, Castration-Resistant / Glucocorticoids / Mycobacterium Type of study: Guideline Limits: Aged / Humans / Male Language: En Journal: Medicine (Baltimore) Year: 2021 Document type: Article Affiliation country: China Country of publication: Estados Unidos